These effects are proportional to weight loss speed and amount, making them slightly more common with tirzepatide due to greater average weight loss
Suicidal behavior and ideation have been reported in clinical trials with other incretin mimetics indicated for weight management
Hadidchi carefully evaluates each patients medical history, metabolic health, and personal preferences before recommending any prescription therapy, including GLP-1 medications, as part of a comprehensive treatment plan
October 10, 2022
Other secondary measures also favored semaglutide, with reductions in blood levels of certain liver damage markers and in scores on the Enhanced Liver Fibrosis (ELF), a non-invasive test that considers levels of three blood biomarkers to estimate liver fibrosis
The Food and Drug Administration (FDA) recommends people who have a personal or family history of medullary thyroid cancer (MTC) should not use Zepbound along with people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
:max_bytes(150000):strip_icc()/VWH-GettyImages-1807239973-13b3185e5c224ffa8eafa762fae1ef8d.jpg)
.png.jpg)
